Myriad Genetics Company
Myriad Genetics offers a personal and thoughtful genetic insights experience for healthcare providers and the women who rely on them, with the highest level of rigor, intention, and humanity. Their genetic screens and tests provide actionable information, empowering women and their families to make critical and timely healthcare decisions, whether they’re thinking about starting a family or evaluating risk for cancer. Myriad invests in advanced AI and Machine Learning analytics, uses AI to make discoveries, improves current tests, and uses its genomic and phenotypic information to predict cancer risk more accurately.
Technology:
Pregnancy biomarkers, Biomarkers of Female Cancers
Headquarters:
Salt Lake City, Utah, United States
Acquisitions Number:
9
Founded Date:
1991
Industry:
Women's Longevity
Employee Number:
1001-5000
Estimated Revenue:
$100M to $500M
Funding Status:
IPO